Posted by Michael Wonder on 07 Dec 2023
Evolving our approach to COVID-19 vaccines and treatments
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours.
In October, PHARMAC widened access to COVID-19 anti-virals to people who are vulnerable to severe infection from COVID-19, including those with disabilities and with one or more severe health conditions.
